HADHA and hepatocellular carcinoma: Indeed, miR-612 has been shown to suppress the migration and invasion of HCC, partially by HADHA-mediating lipid reprogramming, and to inhibit the formation of invadopodia and Wnt/β-catenin-regulated EMT progression 29.